Acute Candida albicans Peritonitis in a Patient with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab

Perit Dial Int. 2019 Nov-Dec;39(6):575-576. doi: 10.3747/pdi.2019.00094.
No abstract available

Keywords: Interventional nephrology; fungal peritonitis.

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Acute Disease
  • Adult
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Atypical Hemolytic Uremic Syndrome / complications
  • Atypical Hemolytic Uremic Syndrome / therapy*
  • Candida albicans / isolation & purification*
  • Candidiasis / drug therapy*
  • Candidiasis / etiology
  • Candidiasis / microbiology
  • Complement Inactivating Agents / therapeutic use
  • Female
  • Humans
  • Peritoneal Dialysis / adverse effects*
  • Peritonitis / drug therapy*
  • Peritonitis / etiology
  • Peritonitis / microbiology

Substances

  • Antibodies, Monoclonal, Humanized
  • Complement Inactivating Agents
  • eculizumab